Cancer Combination Therapies - the 3rd AstraZeneca-MedImmune-CRUK Cambridge Cancer Science Symposium will take place on 25-26 September 2017 at Churchill College.
Cambridge scientists are set to play a key role in the development of new treatments for pancreatic cancer after a £10 million investment from Cancer Research UK.